Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation

  title={Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation},
  author={Laura J. Mosher and Roberto Cadeddu and Sabrina Yen and Jeff L. Staudinger and Francesco Traccis and Stephen C. Fowler and Jamie L. Maguire and Marco Bortolato},

Figures from this paper

Acute stress impairs sensorimotor gating via the neurosteroid allopregnanolone in the prefrontal cortex
It is shown that, in several rodent models of psychopathology, the neurosteroid allopregnanolone reduces the prepulse inhibition of the startle, a well-validated index of sensorimotor gating, and that acute stress impairs PPI by increasing AP content in the mPFC.
Allopregnanolone: An overview on its synthesis and effects
Synthetic analogues or a different therapeutic strategy able to increase allopregnanolone levels have been proposed to overcome any pharmacokinetic issues and a possible gender medicine based on this neuroactive steroid for neurological disorders.
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?
Results indicate that inhibiting AP synthesis and signalling reduces the exacerbation of tic severity associated with acute stress, and point to the possibility that the GABAergic activation by AP may also lead to disinhibitory effects, which could interfere with the ability of patients to suppress their tics.
Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids
This scenario suggests that the synthesis of neuroactive steroids during acute SD may be enacted as a neuroprotective response in the PFC; however, such compensation may in turn set off neurobehavioural complications by interfering with the corticolimbic connections responsible for executive functions and emotional regulation.


Activation of D1, but not D2 Receptors Potentiates Dizocilpine-Mediated Disruption of Prepulse Inhibition of the Startle
It is suggested that D1, but not D2 receptors, enhance the disruptive effect of dizocilpine on PPI, as well as haloperidol or clozapine, which are ineffective per se.
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Potential species differences in the DA receptor modulation of PPI between rats and mice are revealed, where D1-family receptors may play a more prominent and independent role in the modulating PPI in mice than in rats.
Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation
Dopamine D1 and D2 Agonist Effects on Prepulse Inhibition and Locomotion: Comparison of Sprague-Dawley Rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J Mice
D2 receptors have been studied in relation to therapeutic uses of dopaminergic drugs, and psychomotor stimulant effects [as manifested by decreased prepulse inhibition (PPI) of startle and increased
Antipsychotic-Like Properties of 5-α-Reductase Inhibitors
The results suggest that 5AR inhibitors elicit antipsychotic-like effects in animals and may be proposed as a putative novel target in the management of psychotic disorders.
Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models
It is suggested that stress may exacerbate TS symptoms by promoting allopregnanolone synthesis in the PFC, and corroborate previous clinical results pointing to finasteride as a novel therapeutic avenue to curb symptom fluctuations in TS.
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
While the PPI model based on the effects of direct DA agonists is the most well-validated for the identification of known antipsychotic drugs, the isolation rearing model also appears to be sensitive to both typical and atypical antipsychotics, and the 5-HT P PI model is less generally sensitive to antippsychotic medications, but can provide insight into the contribution of serotonergic systems to the actions of newer antipsychosis that act upon multiple receptors.
Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor
Understanding of allopregnanolone’s actions in the VTA for lordosis has been extended to reveal the role ofallopreg nanolone for broader, clinically-relevant questions, such as neurodevelopmental processes, neuropsychiatric disorders, epilepsy, and aging.